Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Michela Gabaldo

Michela Gabaldo

Head Alliance Management & Regulatory Affairs, Fondazione Telethon

Michela Gabaldo is the Head of Alliance Management & Regulatory Affairs at Fondazione Telethon in Milan supporting the 2 internal Scientific Institutes through the clinical development up to the registration and market access of the gene therapy programs developed internally and in partnership with Pharmaceutical industries. She has more than 19 years of experience in drug development spanning from chemicals up to ATMP. She joined Telethon in 2011 where she manages gene therapy projects at different stages of development ranging from preclinical, to clinical, to registration and market access. Winner of 2017 edition of TopRA Award in the Future category, Michela offers up to date knowledge of the most recent regulations in ATMPs and Orphans. She’s currently a member of the IRDIRC Technical Scientific Committee.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd